432 related articles for article (PubMed ID: 34295884)
1.
Li W; Fu Y; Halliday GM; Sue CM
Front Cell Dev Biol; 2021; 9():612476. PubMed ID: 34295884
[TBL] [Abstract][Full Text] [Related]
2. Genes Implicated in Familial Parkinson's Disease Provide a Dual Picture of Nigral Dopaminergic Neurodegeneration with Mitochondria Taking Center Stage.
Franco R; Rivas-Santisteban R; Navarro G; Pinna A; Reyes-Resina I
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924963
[TBL] [Abstract][Full Text] [Related]
3. Mitophagy, a Form of Selective Autophagy, Plays an Essential Role in Mitochondrial Dynamics of Parkinson's Disease.
Wang XL; Feng ST; Wang YT; Yuan YH; Li ZP; Chen NH; Wang ZZ; Zhang Y
Cell Mol Neurobiol; 2022 Jul; 42(5):1321-1339. PubMed ID: 33528716
[TBL] [Abstract][Full Text] [Related]
4. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
5. Role of the endolysosomal system in Parkinson's disease.
Vidyadhara DJ; Lee JE; Chandra SS
J Neurochem; 2019 Sep; 150(5):487-506. PubMed ID: 31287913
[TBL] [Abstract][Full Text] [Related]
6. Post-translational modification and mitochondrial function in Parkinson's disease.
Luo S; Wang D; Zhang Z
Front Mol Neurosci; 2023; 16():1329554. PubMed ID: 38273938
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease.
Ryan BJ; Hoek S; Fon EA; Wade-Martins R
Trends Biochem Sci; 2015 Apr; 40(4):200-10. PubMed ID: 25757399
[TBL] [Abstract][Full Text] [Related]
8. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
Büeler H
Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
[TBL] [Abstract][Full Text] [Related]
9. Mutations in CHCHD2 cause α-synuclein aggregation.
Ikeda A; Nishioka K; Meng H; Takanashi M; Hasegawa I; Inoshita T; Shiba-Fukushima K; Li Y; Yoshino H; Mori A; Okuzumi A; Yamaguchi A; Nonaka R; Izawa N; Ishikawa KI; Saiki H; Morita M; Hasegawa M; Hasegawa K; Elahi M; Funayama M; Okano H; Akamatsu W; Imai Y; Hattori N
Hum Mol Genet; 2019 Dec; 28(23):3895-3911. PubMed ID: 31600778
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of molecular approaches that link mitochondrial dysfunction and neuroinflammation in Parkinson's disease.
Mani S; Sevanan M; Krishnamoorthy A; Sekar S
Neurol Sci; 2021 Nov; 42(11):4459-4469. PubMed ID: 34480241
[TBL] [Abstract][Full Text] [Related]
11. Autophagy and Parkinson's Disease.
Lu J; Wu M; Yue Z
Adv Exp Med Biol; 2020; 1207():21-51. PubMed ID: 32671737
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial dysfunction and biogenesis in the pathogenesis of Parkinson's disease.
Lin TK; Liou CW; Chen SD; Chuang YC; Tiao MM; Wang PW; Chen JB; Chuang JH
Chang Gung Med J; 2009; 32(6):589-99. PubMed ID: 20035637
[TBL] [Abstract][Full Text] [Related]
13. The genetic landscape of Parkinson's disease.
Lunati A; Lesage S; Brice A
Rev Neurol (Paris); 2018 Nov; 174(9):628-643. PubMed ID: 30245141
[TBL] [Abstract][Full Text] [Related]
14. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.
Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM
Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957
[TBL] [Abstract][Full Text] [Related]
15. Age- and disease-dependent increase of the mitophagy marker phospho-ubiquitin in normal aging and Lewy body disease.
Hou X; Fiesel FC; Truban D; Castanedes Casey M; Lin WL; Soto AI; Tacik P; Rousseau LG; Diehl NN; Heckman MG; Lorenzo-Betancor O; Ferrer I; Arbelo JM; Steele JC; Farrer MJ; Cornejo-Olivas M; Torres L; Mata IF; Graff-Radford NR; Wszolek ZK; Ross OA; Murray ME; Dickson DW; Springer W
Autophagy; 2018; 14(8):1404-1418. PubMed ID: 29947276
[TBL] [Abstract][Full Text] [Related]
16. Update on the association between alpha-synuclein and tau with mitochondrial dysfunction: Implications for Parkinson's disease.
Feng ST; Wang ZZ; Yuan YH; Sun HM; Chen NH; Zhang Y
Eur J Neurosci; 2021 May; 53(9):2946-2959. PubMed ID: 32031280
[TBL] [Abstract][Full Text] [Related]
17. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress factors in Parkinson's disease.
Dorszewska J; Kowalska M; Prendecki M; Piekut T; Kozłowska J; Kozubski W
Neural Regen Res; 2021 Jul; 16(7):1383-1391. PubMed ID: 33318422
[TBL] [Abstract][Full Text] [Related]
19. LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson's Disease?
O'Hara DM; Pawar G; Kalia SK; Kalia LV
Front Neurosci; 2020; 14():577. PubMed ID: 32625052
[TBL] [Abstract][Full Text] [Related]
20. Autosomal dominant Parkinson's disease.
Sundal C; Fujioka S; Uitti RJ; Wszolek ZK
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S7-10. PubMed ID: 22166459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
